March 24, 2021
RFA-AI-20-080 - Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases (NIAID)
This Notice is to inform potential applicants of a revision to the Eligibility Information in Funding Opportunity Announcement (FOA) RFA-AI-20-080, "Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)."
Effective immediately, the following section of RFA-AI-20-080, "Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)" has been modified, as indicated below.
Currently Reads:
Section III. Eligibility Information
1. Eligible Applicants
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement are not allowed.
Modified to Read (changes shown in bold italics):
Section III. Eligibility Information
1. Eligible Applicants
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
All other aspects of the FOA remain the same.
Alison Deckhut Augustine, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3475
Email: [email protected]
Alkis Togias, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3587
Email: [email protected]